IRCT2013091112307N2已完成未知
A Randomized, Controlled Trial of Levonorgestrel Vs. The Yuzpe Regimen as Emergency Contraception Method among Iranian Women
by Deputy Ministry for Research Tehran University of Medical Sciences,Population Family and School H0 个研究点目标入组 529 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 529
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 15 years 至 49 years(—)
- 性别
- Female
入选标准
- •Eligible participants were sexually active women aged between 15 and 49 years having regular menstrual cycles of 24-42 days. We also included women having only one act of unprotected intercourse within current cycle and they were asked to take the pills within 72 h of the unprotected intercourse. In addition, the failed contraceptive method was determined to be condom or conventional method. Breast-feeding women were also included provided that their baby was older than 6 months.
- •Exclusion criteria were breast-feeding women with their baby younger than 6 months, hormonal contraindications in their current cycle, use of hormonal contraceptives, uncertainty about the time of LMP, and suspected pregnancy
排除标准
- 未提供
研究者
相似试验
已完成
2 期
A clinical trial to compare effect of adding metformin to progesterone containing intra uterine device in patients with endometrial hyperplasia without atypiaCTRI/2017/05/008548Postgraduate institute of medical education and research51
已完成
不适用
Evaluation of the use of Mirena IUD in patients with increased uterine bleeding with blood clotting disorders.Von Willebrand's diseaseOther coagulation defectsAntepartum haemorrhage with coagulation defectExcessive bleeding in the premenopausal periodD68.0O46.0N92.4RBR-5vyd2xFaculdade de Medicina-Universidade Federal de Minas Gerais
招募中
2 期
Estrogen for the treatment of Borderline Personality DisorderBorderline Personality DisorderACTRN12617001317381Alfred Hospital72
已完成
不适用
RCT comparing insertion of levonorgestrel releasing intrauterine system (Mirena) during the menstruation compared with random insertion beyond menstruations in patient-perceived pain.intrauterine contraceptiveLNG-IUS1001332610029903NL-OMON40263Maxima Medisch Centrum120
已完成
不适用
The PROOF trial: PROtecting Ovaries and Fertility during chemotherapyISRCTN96797814Ottawa Hospital Research Institute (OHRI) (Canada) - formerly Ottawa Health Research Institute30
